Trials / Unknown
UnknownNCT03075969
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 337 (actual)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.
Conditions
Timeline
- Start date
- 2017-08-03
- Primary completion
- 2019-03-16
- Completion
- 2019-12-01
- First posted
- 2017-03-09
- Last updated
- 2019-03-21
Locations
32 sites across 9 countries: United States, Austria, Brazil, China, Germany, Iraq, Italy, Malaysia, Netherlands
Source: ClinicalTrials.gov record NCT03075969. Inclusion in this directory is not an endorsement.